Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby’s Fundus Dystrophy

Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration

(2013) Daniel Ardeljan et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Seven new loci associated with age-related macular degeneration

(2013) Lars G Fritsche et al.   NATURE GENETICS

Ranibizumab for the management of Sorsby fundus dystrophy

(2012) K Balaskas et al.   EYE

The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity

(2010) Keith Brew et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

The significance of the complement system for the pathogenesis of age-related macular degeneration — current evidence and translation into clinical application

(2010) Peter Charbel Issa et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration

(2010) W. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinical Course and Treatment Outcomes of Sorsby Fundus Dystrophy

(2008) Sobha Sivaprasad et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY